0001203311-21-000075.txt : 20210927
0001203311-21-000075.hdr.sgml : 20210927
20210927200906
ACCESSION NUMBER: 0001203311-21-000075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210923
FILED AS OF DATE: 20210927
DATE AS OF CHANGE: 20210927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LIU JEAN I
CENTRAL INDEX KEY: 0001241357
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 211283232
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-09-23
0
0001060736
Seagen Inc.
SGEN
0001241357
LIU JEAN I
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
GC/EVP, Legal Affairs
Common Stock
2021-09-23
4
A
0
160
166.22
A
69091
D
These shares represent restricted stock units and will be settled in common stock upon vesting.
The performance criteria for these restricted stock units were met. These restricted stock units will become fully vested on 09/20/23, subject to continuous service with the Company until the vesting date.
Number of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
By: Jessica Nielsen Causey For: Jean I Liu
2021-09-27